Triverity Laboratories is the embodiment of a shared vision, brought to life by our visionary owners who possess over 40 years of pharmaceutical experience. Driven by a relentless pursuit of excellence, they embarked on a mission to establish a laboratory that sets new benchmarks in analytical precision and compliance.

 

Fueled by their deep-rooted commitment to analytical excellence, Wendi Young and Heather Krebs leveraged their extensive pharmaceutical background and, together with Alix Britton, created Triverity Laboratories. Their collective expertise spans across various domains, including product development, regulatory affairs, quality control, and laboratory management.

​

Having personally encountered the gaps in existing analytical services in the cannabinoid industry, they set out to design a global laboratory specifically for this space. With a blend of pharmaceutical standards, industry wisdom, and an unyielding drive for innovation, Triverity has cultivated an environment where analytical excellence converges seamlessly with compliance solutions.

​

Recently, Triverity Laboratories has expanded its scope to better serve the pharmaceutical industry. Leveraging our extensive pharmaceutical experience, we offer comprehensive analytical development services including method development, specification setting, impurity evaluation, and determination of critical quality attributes. Our experts work closely with clients to design and optimize analytical methods in compliance with European and United States Pharmacopoeia monographs.​

​

Join us on this remarkable journey, where our owners' 40 years of pharmaceutical experience serve as the cornerstone of Triverity Laboratories' commitment to elevating your business to new heights. Experience firsthand the difference that a legacy of knowledge, passion, and dedication can make.​